{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02765399","recordId":"NCT02765399","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02765399-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02765399.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02765399.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-05-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-05-05","publishedAt":"2026-08-23","recordId":"NCT02765399","recordSha256":"a04869dfbd9dedf7a31f85b031299f7b8da46dbe8123d8b05a6381b339f8dbe1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02765399?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-02-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-02-28","publishedAt":"2026-08-23","recordId":"NCT02765399","recordSha256":"de51d0d9b2c0c8146e21f9991cffadcbd5eb71b6142f56b0c08823ed42260975","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02765399?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-01-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-01-24","publishedAt":"2026-08-23","recordId":"NCT02765399","recordSha256":"89a5ad5dc4b1815a0c5ed21d9625d7d0ec44296a9962a0a32b47ca442f506693","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02765399?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2022-04-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2022-04-11","publishedAt":"2026-08-23","recordId":"NCT02765399","recordSha256":"5902fa62b5a86b5b62f95166243dee796c4b342de55c9c31f8e694961a6cbfd4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02765399?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"a801522bd5f1f4ad1a93a769fe2367f0c64f50181727805c027ed573d937a2b3"}}